Skip to main content
Download the Galderma GAIN app to stay connected

Contact Sculptra

Please contact the Galderma Special Services team, available Monday to Friday, from 8:00 AM to 5:00 PM CT.

More ways to contact Galderma 

You can reach our Galderma US Aesthetics Support Team by calling 1-800-221-1749 or emailing inside.sales@galderma.com.

For medical inquiries, including reporting adverse medical reactions to a Galderma product, please call 1-866-735-4137.

For questions about using Sculptra in your practice, and to open an account with Galderma, please contact our team for support.

1-800-221-1749

inside.sales@galderma.com

For questions regarding Sculptra product orders, please contact your Sculptra Account Manager.

Educational resources are available through myGAINtraining.com, which provides training on the anatomy of the treatment area, effective patient assessment, and appropriate injection techniques. Healthcare professionals may contact Galderma for educational and training resources specific to the correction of fine lines and wrinkles in the cheek region.

For support with ordering Sculptra, please contact your Sculptra Account Manager or Customer Support.

1-800-221-1749

inside.sales@galderma.com

Completion of device-specific use training is required and will be verified prior to purchase of Sculptra for the correction of fine lines and wrinkles in the cheek region for use in immune-competent subjects.

For support with your practice listings on our Find a Specialist page, please refer to the ASPIRE Galderma Practice Rewards FAQs or contact our support team.

ASPIRE Practice Rewards Support

1-888-675-3596

ASPIRE Galderma Practice Rewards FAQs

Build your business with ASPIRE Galderma Practice Rewards

Empower business growth. Strengthen patient relationships.

ASPIRE Galderma Practice Rewards is a program designed to strengthen the relationship you build with your aesthetics patients. As your connection grows, so does your practice, and we’re here to support both with valuable insights, product offers, and practice tools.

Give Them the Signature 2-year Sculptra Glow*

Happy Sculptra® patient smiling

Give Them the Signature 2-year Sculptra Glow*

Sculptra isn’t like hyaluronic acid fillers. It’s a long-lasting treatment that addresses collagen loss, an underlying cause of facial aging. Sculptra helps stimulate your patients’ Type 1 collagen and targets fine lines and wrinkles, helps improve skin quality, and restores the skin’s natural glow when injected into the cheek.1-5*

  • 95% of patients had improved skin glow 2 years after Sculptra treatment.
  • Actual patient. Individual results may vary.

How PLLA-SCA works

Drawing of a Sculptra injection

How PLLA-SCA works

Sculptra is made of poly-L-lactic acid (PLLA-SCA), which helps stimulate natural collagen to support the skin’s structure, reduce wrinkles and improve skin quality when injected into the cheek area.1-5*

Here’s how it works:

  • PLLA-SCA is injected into the deep dermis.2,4
  • PLLA-SCA microparticles recruit fibroblasts.2,4
  • The fibroblasts deposit new collagen in the tissue, helping reinforce the skin’s inner structure and foundation.2-5

  • 95% of patients had improved skin glow 2 years after Sculptra treatment.5
Drawing of  a Sculptra injection

Sculptra works deep within the skin

PLLA-SCA works underneath the skin to help restore the skin’s inner structure.1,2
Drawing of collagen stimulation

Stimulating natural collagen

As Sculptra PLLA-SCA microparticles are absorbed, they help stimulate and restore your own natural collagen production.2,5
Drawing of collagen restoration

Gradually restoring skin quality3,4

Collagen strands begin to rebuild gradually, helping to restore skin structure and reducing the appearance of wrinkles and folds.5
References
  1. Sculptra. Instructions for Use. Galderma Laboratories, L.P., 2023.
  2. Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915-922.
  3. Bohnert K, Dorizas A, Lorenc P, Sadick NS. Randomized, controlled, multicentered, double-blind investigation of injectable poly-L-lactic acid for improving skin quality. Dermatol Surg. 2019;45:718-724.
  4. Data on file. 43USSA1812EXT Clinical study report. Fort Worth, TX: Galderma Laboratories, L.P., 2022.
  5. Fitzgerald R, Bass LM, Goldberg DJ, Graivier MH, Lorenc ZP. Physiochemical characteristics of poly-L-lactic acid (PLLA). Aesthet Surg J. 
2018;38(suppl 1):S13-S17.
Please see full Important Safety Information
for Sculptra, for frown lines between the brows, including Distant Spread of Toxin Effect Boxed Warning at bottom of page.
Important Safety Information:

Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles.

Important Safety Information

Indication: Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles.

Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age.

Sculptra has unique injection requirements and should only be used by a trained healthcare practitioner. Contour deficiencies should not be overcorrected because they are expected to gradually improve after treatment.

Sculptra should not be injected into the blood vessels as it may cause vascular occlusion, infarction or embolic phenomena. Use at the site of skin sores, cysts, pimples, rashes, hives or infection should be postponed until healing is complete. Sculptra should not be injected into the red area (vermillion) of the lip or in the peri-orbital area.

The most common side effects after initial treatment include injection site swelling, tenderness, redness, pain, bruising, bleeding, itching and lumps. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported.

Sculptra is available only through a licensed practitioner. View the complete Instructions for Use.

Instructions for Use
Patient Safety Information

US-SCA-2300142